What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
How does systemic action work for a peptide
I., Halvorson, L
For more information, ask your healthcare provider or pharmacist
Results showed 87.5% (14 of 16) experienced pain relief, with 91.6% responding to BPC-157 alone without additional treatments
As the premier destination for peptides for sale, we ensure every vial is vacuum-sealed and stabilized for high-impact laboratory applications